This year has seen a number of tech giants like Snap, Cloudera, and Roku, make the jump into public markets. Meanwhile, one lesser-known company, Alteryx, which made its IPO in March, is quietly raking in the gains. Dean Stoecker, CEO of Alteryx, an analytics platform for enterprises, joined Cheddar to explain what’s clicking for his company.
The company's stock is up significantly from its IPO price of $14 a share. Stoecker explains how Alteryx's uncoventional path to IPO set the analytics company up for a strong start. He says raising money is a weakness, not a strength. That's why it took him 14 years to take in investments, and 20 years to move into the public spotlight.
Stoecker says Alteryx is bringing the thrill back to analytics. The company has a giant list of customers, including Walmart and Boeing. The CEO breaks down how Alteryx is looking to change the way these companies interpret data.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
